| http://www.w3.org/ns/prov#value | - Mr. Daniel Perry remarked that the evolution among advocacy organizations from simply pushing for more funding to the NIH to now focusing on the ability of NIH, FDA, and other organizations to produce something of value to the organizations??? constituents.
|
